Es gab 50 kürzliche Insider-Transaktionen für Enveric Biosciences, Inc. (ENVB), darunter 38 Käufe und 0 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $138.31K und die gesamten Insider-Verkäufe auf RSU Award.
Bedeutende Insider mit kürzlicher Aktivität umfassen Webb Michael D, Pasqualone Frank, Schabacker Marcus. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — ENVB
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2025-12-23 |
Webb Michael D |
Director |
RSU-Zuteilung |
7,633 |
- |
- |
7,898 |
| 2025-12-23 |
Pasqualone Frank |
Director |
RSU-Zuteilung |
7,633 |
- |
- |
7,904 |
| 2025-12-23 |
Schabacker Marcus |
Director |
RSU-Zuteilung |
7,633 |
- |
- |
7,900 |
| 2025-12-23 |
Kegler George A. |
Director |
RSU-Zuteilung |
7,633 |
- |
- |
7,900 |
| 2025-12-23 |
Tucker Joseph Edward |
Chief Executive Officer |
RSU-Zuteilung |
60,296 |
- |
- |
70,355 |
| 2025-12-23 |
Coveney Kevin Michael |
Chief Financial Officer |
RSU-Zuteilung |
40,198 |
- |
- |
47,413 |
| 2025-12-23 |
Dewitt Sheila |
Director |
RSU-Zuteilung |
7,633 |
- |
- |
7,788 |
| 2025-05-08 |
Tucker Joseph Edward |
Chief Executive Officer |
RSU-Zuteilung |
98,866 |
- |
- |
120,711 |
| 2025-05-08 |
Facchini Peter J. |
Chief Innovation Officer |
RSU-Zuteilung |
24,717 |
- |
- |
33,058 |
| 2025-05-08 |
Coveney Kevin Michael |
Chief Financial Officer |
RSU-Zuteilung |
74,150 |
- |
- |
86,584 |
| 2024-10-09 |
Webb Michael D |
Director |
RSU-Zuteilung |
47,733 |
- |
- |
47,733 |
| 2024-10-09 |
Pasqualone Frank |
Director |
RSU-Zuteilung |
47,733 |
- |
- |
48,733 |
| 2024-10-09 |
Schabacker Marcus |
Director |
RSU-Zuteilung |
47,733 |
- |
- |
48,053 |
| 2024-10-09 |
Kegler George A. |
Director |
RSU-Zuteilung |
47,733 |
- |
- |
48,053 |
| 2024-10-09 |
Tucker Joseph Edward |
Chief Executive Officer |
RSU-Zuteilung |
161,633 |
- |
- |
335,829 |
| 2024-10-09 |
Facchini Peter J. |
Chief Innovation Officer |
RSU-Zuteilung |
40,000 |
- |
- |
130,856 |
| 2024-10-09 |
Coveney Kevin Michael |
Chief Financial Officer |
RSU-Zuteilung |
100,000 |
- |
- |
186,500 |
| 2024-10-09 |
Dewitt Sheila |
Director |
RSU-Zuteilung |
27,845 |
- |
- |
27,845 |
| 2024-05-28 |
Dewitt Sheila |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2024-02-22 |
Tucker Joseph Edward |
Chief Executive Officer |
RSU-Zuteilung |
100,000 |
- |
- |
174,196 |
| 2024-02-22 |
Facchini Peter J. |
Chief Innovation Officer |
RSU-Zuteilung |
50,000 |
- |
- |
90,856 |
| 2024-02-22 |
Coveney Kevin Michael |
Chief Financial Officer |
RSU-Zuteilung |
60,000 |
- |
- |
86,500 |
| 2023-09-15 |
Pasqualone Frank |
Director |
Informierter Kauf |
1,000 |
$2.14 |
$2.14K |
1,000 |
| 2023-03-13 |
Coveney Kevin Michael |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2023-03-13 |
Coveney Kevin Michael |
Chief Financial Officer |
RSU-Zuteilung |
26,500 |
- |
- |
26,500 |
| 2023-01-25 |
Kanubaddi Avani |
President and COO |
RSU-Zuteilung |
10,000 |
- |
- |
48,346 |
| 2023-01-25 |
Hagel Jillian Marie |
Vice President of Innovation |
RSU-Zuteilung |
12,000 |
- |
- |
35,802 |
| 2023-01-25 |
Tucker Joseph Edward |
Chief Executive Officer |
RSU-Zuteilung |
44,000 |
- |
- |
74,196 |
| 2023-01-25 |
Facchini Peter J. |
Chief Innovation Officer |
RSU-Zuteilung |
17,000 |
- |
- |
40,865 |
| 2022-09-09 |
Dickey Robert Iv |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2022-07-13 |
Pasqualone Frank |
Director |
Unbekannt |
- |
- |
- |
- |
| 2022-06-13 |
Webb Michael D |
Director |
Unbekannt |
- |
- |
- |
- |
| 2022-06-13 |
O'neil Bevin |
Director |
Unbekannt |
- |
- |
- |
- |
| 2022-01-19 |
Ward Carter Julian |
Chief Financial Officer |
RSU-Zuteilung |
744,429 |
- |
- |
744,429 |
| 2022-01-19 |
Kanubaddi Avani |
President and COO |
RSU-Zuteilung |
1,127,787 |
- |
- |
1,127,787 |
| 2021-10-13 |
Hagel Jillian Marie |
Chief Technology Officer |
RSU-Zuteilung |
1,021 |
- |
- |
13,302 |
| 2021-10-13 |
Tucker Joseph Edward |
Chief Executive Officer |
RSU-Zuteilung |
1,374 |
- |
- |
15,196 |
| 2021-10-13 |
Facchini Peter J. |
Chief Scientific Officer |
RSU-Zuteilung |
1,021 |
- |
- |
13,356 |
| 2021-09-16 |
Thompson Bradley George |
Director |
Unbekannt |
- |
- |
- |
- |
| 2021-09-16 |
Thompson Bradley George |
Director |
RSU-Zuteilung |
53,160 |
$0.94 |
$49.97K |
53,160 |
| 2021-09-16 |
Tucker Joseph Edward |
Chief Executive Officer |
Unbekannt |
- |
- |
- |
- |
| 2021-09-16 |
Tucker Joseph Edward |
Chief Executive Officer |
RSU-Zuteilung |
13,290 |
$2.82 |
$37.48K |
13,290 |
| 2021-09-16 |
Tucker Joseph Edward |
Chief Executive Officer |
RSU-Zuteilung |
13,290 |
$2.82 |
$37.48K |
13,290 |
| 2021-09-16 |
Facchini Peter J. |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2021-09-16 |
Facchini Peter J. |
Chief Scientific Officer |
RSU-Zuteilung |
2,658 |
$2.82 |
$7.5K |
2,658 |
| 2021-09-16 |
Hagel Jillian Marie |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2021-09-16 |
Hagel Jillian Marie |
Chief Technology Officer |
RSU-Zuteilung |
1,329 |
$2.82 |
$3.75K |
1,329 |
| 2021-05-15 |
Ward Carter Julian |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2021-03-18 |
Lind Douglas |
Director |
RSU-Zuteilung |
2,265 |
- |
- |
2,265 |
| 2021-03-17 |
Lind Douglas |
Director |
Unbekannt |
- |
- |
- |
- |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall